Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.

Au, Wing-Yan

Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. [electronic resource] - Leukemia research Oct 2005 - 1213-5 p. digital

Publication Type: Case Reports; Journal Article

0145-2126

10.1016/j.leukres.2005.02.018 doi


Adult
Alemtuzumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--therapeutic use
Antilymphocyte Serum--administration & dosage
Antineoplastic Agents--therapeutic use
Cyclophosphamide--administration & dosage
Cyclosporine--administration & dosage
Dexamethasone--administration & dosage
Drug Resistance, Neoplasm
Humans
Leukemia, T-Cell--complications
Male
Mitoxantrone--administration & dosage
Prednisolone--administration & dosage
Red-Cell Aplasia, Pure--complications
Remission Induction
Vidarabine--administration & dosage